← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2010Last known activity
Jan 13, 2025
Timeline
1990s
- Jun 1, 1997
Valenta Pharm JSC— Founded
Drugs by trial phase (20 distinct, 31 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (36)
- NCT06843044Lead sponsorPhase 4Jan 13, 2025
- NCT06859281Lead sponsorPhase 1Dec 10, 2024
- NCT06857890Lead sponsorPhase 1Dec 9, 2024
- NCT06843018Lead sponsorPhase 2Nov 14, 2024
- NCT06842966Lead sponsorPhase 2Oct 17, 2024
- NCT06342778Lead sponsorPhase 1Feb 27, 2024
- NCT06321341Lead sponsorPhase 4Jan 24, 2024
- NCT06096571Lead sponsorN/AJan 15, 2024
- NCT06098742Lead sponsorN/AJan 15, 2024
- NCT06315400Lead sponsorPhase 4Dec 19, 2023
- NCT06379542Lead sponsorPhase 3Dec 4, 2023
- NCT05586789Lead sponsorPhase 3Aug 31, 2022
- NCT05558462Lead sponsorN/AAug 22, 2022
- NCT05544916Lead sponsorPhase 3Aug 5, 2022
- NCT05561816Lead sponsorPhase 3Jul 19, 2022
Details
- Founded
- Moscow, RU Jun 1, 1997
- Last known activity
- Jan 13, 2025
Notes
No evidence of NME R&D